Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
18F-FAPIBiotin
- Development stage
- Unknown
- Lead developer
- Yantai Lannacheng Biotechnology
- Modality
- Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptide-Drug Conjugates → Peptide Conjugates → Peptides
- Administration
- Intravenous
01
Overview
18F-FAPIBiotin is a novel dual-targeting PET radiotracer designed for cancer imaging. It combines a fibroblast activation protein inhibitor (FAPI) with biotin and is labeled with the positron-emitting radionuclide fluorine-18 (18F). The compound targets fibroblast activation protein (FAP), which is overexpressed in cancer-associated fibroblasts within the tumor microenvironment, enabling sensitive detection of various cancers via PET/CT imaging. The addition of biotin may enhance targeting or facilitate further molecular interactions. Early clinical studies have focused on evaluating its safety, biodistribution, radiation dosimetry, and diagnostic efficacy compared to other tracers such as 18F-FDG and standard FAPI tracers[3][6].
- Other names
- 18F-FAPI-Biotin
02
Targets
FAP (Fibroblast activation protein alpha)
Beyond the preview
Go deeper on 18F-FAPIBiotin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 18F-FAPIBiotin.